WASHINGTON (dpa-AFX) - Insmed (INSM) reported a first quarter net loss of $163.6 million, or $0.76 per share, compared to a net loss of $256.6 million, or $1.42 per share, a year ago. Product revenues, net, was $305.96 million compared to $92.82 million.
The company reiterated 2026 BRINSUPRI revenue guidance of at Least $1 billion and 2026 ARIKAYCE revenue guidance of $450 million to $470 million.
As of March 31, 2026, Insmed had cash, cash equivalents, and marketable securities totaling approximately $1.2 billion.
In pre-market trading on NasdaqGS, Insmed shares are down 5.15 percent to $130.04.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
Copyright(c) 2026 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
© 2026 AFX News
